Luminescence-based analysis that facilitates the measurement of multiple metabolites from small sample volumes for use in point-of-care or in-home environments. Part of our interest in this project is in patient empowerment-getting patients to assume responsibility and control of their own diseases. Our goal is a Chem-Chip system that is analogous to the present generation of glucose dipsticks and glucometers in terms of ease of use, quality of data, and low cost. If the potential of the Chem-Chip is realized, practically all relevant disease markers over a wide range of molecular weights and concentrations could be quantitatively and specifically measured for disease diagnosis and management.
No takes yet. Share an insight, caveat, or question.
Davies et al. (2003) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: